This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CASSS Community News - April 25, 2019
Share |

 

IN THIS ISSUE

CE PHARM | COMPETITIVE LANDSCAPE STUDY DID YOU KNOW? 


 

 

 

 

 

 

 

 

Save the Date: Attend CE Pharm 2019 This Fall

Mark your calendars for CE Pharm 2019 on September 29 – October 2, 2019 at the Hyatt Regency Hotel in Bethesda, MD, USA.This Symposium is on the recent developments in CE analysis of protein, nucleotide, and small molecule pharmaceuticals. Applications will highlight uses of CE in various areas of product development, including high throughput screening, formulation studies, process development, product characterization, and validated lot release and stability testing.

Topics for this year’s program include: Affinity Chromatography/Emerging Separation Approaches, CE-Hyphen Techniques, Complex and Unusual Molecules, Method Validation, Regulatory, Unique Formulations / Separation Challenges, Unmet Needs in Characterization, Uses of CE to Answer “Weird” Questions, Young Scientist. 

See What You Missed in 2018: A robust three-day program with industry experts, roundtable discussions, and an interactive troubleshooting workshop. To view the 2018 scientific program, click HERE.

 



CASSS Has Conducted a Competitive Landscape Study

CASSS recently commissioned Allis Information Management to complete a competitive landscape study that compared CASSS operations with six non-profit associations serving the biopharma industry. The goal was to identify areas of opportunity and industry best practices. The study provided key insights and validation of CASSS priorities. Here are several highlights from the report:
  • CASSS is the only organization in the group that does not charge dues to become a member.This is a competitive advantage to engage new members, especially those early in their careers.
  • CASSS has – by far – the largest percentage of revenues allocated towards conference expenditures.This is in-line with CASSS’s commitment to provide an excellent experience for every member attending a CASSS conference.
  • CASSS was the first of the competitive set to take advantage of live-streaming and on-demand video with its introduction at the WCBP 2019 conference. Stay tuned for more streaming options in the future.
  • The study highlights the need for CASSS to expand its marketing and communication strategies in order to engage a more diverse audience, especially reaching out to the smaller biopharma companies and early-career practitioners.

To view the report, click HERE. Any questions? Contact Rich Benci at rich [at] benci.net.

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Did You Know? CASSS’s Three Pillars

Over the past decade CASSS has transitioned from an organization that lacked focus to one that is clear in its purpose and commitment to members: CASSS enables global access, knowledge sharing, and regulatory capacity building by bringing together professionals from industry, academia, and regulatory agencies to solve scientific and technical problems in order to advance the development of biopharmaceuticals.

Adopted in 2015, this Vision 2030 is our compass, guiding decisions and investments of time and resources. This is critical, as we have grown to a membership that includes 300 regulatory agency representatives from 32 regulatory agencies, and members from Africa, Asia, Australia, Canada, Europe, Latin America, the Middle East, and the United States. Below you’ll find descriptions of each Vision 2030 pillar.

Global Access: CASSS is a global hub for best practices and technical information in biopharma development and regulation through symposia, fora, and discussion groups, connecting industry professionals, subject matter experts, health authorities, academia, and instrument developers.

Knowledge Sharing: CASSS fosters innovation through a free of exchange of knowledge, aligning global industry with local issues, and serve as a bridge between innovation and delivery to encourage breakthroughs in science and bring innovative products to market.

Regulatory Capacity Building: CASSS facilitates agency to agency dialogue and interaction to break down barriers and serve as a catalyst for progress. We provide a forum for highly ethical, scientifically sound, and innovative paths for development of biologically derived medicines.


Upcoming CASSS Meetings


EARLY BIRD REGISTRATION ENDS MAY 3

ONLINE REGISTRATION CLOSES MAY 24

SAVE THE DATE! SEPTEMBER 17-20

SAVE THE DATE! SEPT 29-OCT 2

Membership Software Powered by YourMembership  ::  Legal